Overview / Abstract: |
As the landscape of compounding peptides and semaglutide continues to evolve rapidly, a multitude of legal challenges and opportunities arise. This session aims to shed light on the pivotal developments and regulatory nuances in this dynamic sector. Our speakers will delve into critical topics such as the FDA's current stance on peptide compounding, recent pronouncements from state Boards of Pharmacy, and the intricate legalities surrounding brand manufacturers. Additionally, the webinar will explore the burgeoning realm of telemedicine and its implications for compounders, along with guidance on navigating the complexities of bulk chemical ingredients. This Educational Activity is supported by the American College of Apothecaries and is designed to educate healthcare professionals. |
Expiration |
Feb 22, 2027 |
Discipline(s) |
Pharmacy CPE |
Format |
Online, Webinar / Webcast / Video |
Cost |
Members: $30 | Non-Members: $50 |
Credits / Hours |
1.0 |
Accreditation |
The American College of Apothecaries (ACA) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACA has accredited this program for 1 contact hour (0.1 CEU) of continuing education credit for pharmacists and pharmacy technicians. |
Presenters / Authors / Faculty |
Martha M. Rumore, PharmD, Esq, MS, LLM, FAPhA |
Keywords / Search Terms |
American College of Apothecaries, Pharmacists, Pharmacy Technicians, Compounding, Semaglutide, Peptides, Pharmacy Law, Regulatory Issues, Telemedicine/Telepharmacy, CE, Webinar |